- May Hegglin anomaly
Infobox_Disease
Name = PAGENAME
Caption =
DiseasesDB = 29517
ICD10 = ICD10|D|72|0|d|70
ICD9 = ICD9|288.2
ICDO =
OMIM = 155100
MedlinePlus =
eMedicineSubj = ped
eMedicineTopic = 1383
MeshID =May Hegglin's anomaly, as it is also known, is a rare genetic disorder of the blood
platelets that causes them to be abnormally large. Also, this anomaly causes abnormalities in thewhite blood cell s known asleukocytes . This disorder was first described by Richard May, a German physician, in 1909, and was subsequently described by a Swiss physician,Robert Hegglin , in 1945. The pathogenesis of the disorder had been unknown until recently, when mutations in the gene encoding for nonmusclemyosin heavy chain IIA (MYH9 ) were identified. Unique cytoplasmic inclusion bodies are aggregates of nonmuscle myosin heavy chain IIA, and are only present ingranulocyte s. It is not yet known why inclusion bodies are not present in platelets, monocytes, and lymphocytes, or how giant platelets are formed. Interestingly,MYH9 is also found to be responsible for several related disorders withmacrothrombocytopenia and leukocytes inclusion, including Sebastian, Fechtner, and Epstein syndromes, which feature deafness, nephritis, and/or cataract [cite journal
quotes = yes
last=Saito
first=Hidehiko
authorlink=
coauthors=Kunishima Shinji
year=2008 |month=Apr.title=Historical hematology: May-Hegglin anomaly
journal=Am. J. Hematol.
volume=83
issue=4
pages=304-6
publisher = | location = | issn =
pmid = 17975807
doi = 10.1002/ajh.21102
bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = ] .Presentation
In the leukocytes, the presence of very small rods (around 3 micrometers), or
Dohle bodies can be seen in thecytoplasm .Treatment
In many cases, May Hegglin's requires no treatment. However, in extreme cases, blood platelet transfusions may be necessary
Causes
Wikimedia Foundation. 2010.